Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-02

FDA Approved: COLESEVELAM HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc.,USA)

View source ↗

Summary

FDA approved a supplemental application for Colesevelam hydrochloride (generic) from Glenmark Pharmaceuticals Inc., USA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Colesevelam hydrochloride (Colesevelam hydrochloride)

Snippet

SUPPL AP for COLESEVELAM HYDROCHLORIDE (COLESEVELAM HYDROCHLORIDE)